Alexandra I. Halalau

Alexandra Halalau practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health.

Alexandra Halalau's NPI, 1033324280, was assigned on May 11, 2007. Alexandra Halalau holds Michigan license 4301085329.

Alexandra Halalau's primary practice is Corewell Health William Beaumont University Hospital, at 3601 W Thirteen Mile Rd, Royal Oak, MI 48073 in Oakland County. The practice phone is (248) 898-5400.

Alexandra Halalau's primary practice is Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health. Alexandra Halalau is also affiliated with Corewell Health Beaumont Troy Hospital. The medical group on file is Medical Education Associates. Dmand AI also links Alexandra Halalau to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Alexandra Halalau practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Alexandra Halalau's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Alexandra Halalau is licensed in Michigan.

CMS data shows 248 Medicare services from Alexandra Halalau across 6 procedure codes in 2024, for 118 Medicare patients. Medicare paid $10,973 for them.

CMS counts 118 Medicare patients who saw Alexandra Halalau in 2024. The largest group is 65 to 74, with 55 patients. 66% of them have high cholesterol, and 65% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Alexandra Halalau's median patient age at 58, with 70% women.

In 2024, Alexandra Halalau wrote 1,578 Medicare Part D claims for 195 patients. 87% of them were for generic drugs. CMS names the drug for 1,122 of them, across 33 drugs with 11 or more claims each, at $51,917 in total drug cost. In 2023, CMS named 1,108 claims across 32 drugs.

Alexandra Halalau accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Alexandra Halalau as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 59 papers to Alexandra Halalau, published from 2016 to 2024. 2018 was the busiest year, with 12. The most frequent topics are COVID-19, Michigan and Diabetes Mellitus, Type 2. Alexandra Halalau has published most often in Int J Gen Med. Alexandra Halalau's most frequent co-authors are Adam Hafeez, MD, Zaid Imam, MD and Amr E. Abbas, MD.

Dmand AI links Alexandra Halalau to 1 clinical trial. Conditions studied include Patient Compliance and Patient Acceptance of Health Care.

CMS Open Payments shows 1 general payment to Alexandra Halalau from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $18.